Effects of Gastric Bypass on Blood Levels of Duloxetine
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine
between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control
subjects matched for body mass index (BMI), age and gender.
Phase:
Phase 3
Details
Lead Sponsor:
Neuropsychiatric Research Institute, Fargo, North Dakota